`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE SOUTHERN DISTRICT OF INDIANA
`INDIANAPOLIS DIVISION
`
`
`Plaintiff,
`
`v.
`
`)
`ELI LILLY AND COMPANY,
`
`)
`
`
`)
`
`
` )
`
` ) Civil Action No. 1:10-cv-01376-TWP-DKL
`
` )
`
`
`
` )
`TEVA PARENTERAL MEDICINES, INC.,
` )
`APP PHARMACEUTICALS, LLC,
` )
`PLIVA HRVATSKA D.O.O.,
`TEVA PHARMACEUTICALS USA, INC., and )
`BARR LABORATORIES, INC.,
` )
`
` )
`
` )
`
` )
`
`Defendants.
`
`
`
`
`
`
`
`STIPULATION REGARDING POST-TRIAL BRIEFING SCHEDULE
`
`As directed in this Court’s Entry Following Bench Trial Held August 29, 2013 (ECF
`
`No. 317), Plaintiff Eli Lilly and Company (“Lilly”) and Defendants Teva Parenteral
`
`Medicines, Inc., APP Pharmaceuticals, LLC, Pliva Hrvatska d.o.o., Teva Pharmaceuticals
`
`USA, Inc., and Barr Laboratories, Inc., have conferred and hereby agree to the following
`
`schedule for post-trial briefing:
`
`
`
`Defendants shall file an opening brief of up to 50 pages on or before Friday, October
`
`11, 2013.
`
`
`
`Lilly shall file a responsive brief of up to 60 pages on or before Friday, November 22,
`
`2013.
`
`
`
`Defendants shall file a reply brief of up to 15 pages on or before Tuesday, December
`
`17, 2013.
`
`
`
`1
`
`By tpratt at 3:01 pm, Sep 04, 2013
`
`
`
`Case 1:10-cv-01376-TWP-DKL Document 319 Filed 09/04/13 Page 2 of 3 PageID #: 6307
`
`
`Respectfully submitted,
`
`
`
` /s/ Kandi Kilkelly Hidde (with permission)
`David O. Tittle
`Kandi Kilkelly Hidde
`BINGHAM MCHALE LLP
`10 West Market Street
`Market Tower, Suite 2700
`Indianapolis, IN 46204
`(317) 635-8900
`Fax: (317) 236-9907
`dtittle@bgdlegal.com
`khidde@bgdlegal.com
`
`Daryl L. Wiesen
`Elaine Herrmann Blais
`Emily L. Rapalino
`GOODWIN PROCTER LLP
`53 State Street
`Boston, MA 02109
`(617) 570-1000
`dwiesen@goodwinprocter.com
`eblais@goodwinprocter.com
`erapalino@goodwinprocter.com
`
`
`Michael B. Cottler
`Brian J. Prew
`Natasha E. Daughtrey
`GOODWIN PROCTER LLP
`620 Eighth Avenue
`New York, NY 10018
`(212) 813-8800
`mcottler@goodwinprocter.com
`bprew@goodwinprocter.com
`ndaughtrey@goodwinprocter.com
`
`Attorneys for Defendants
`
`2
`
`
`Dated: September 3, 2013
`
`
`
` /s/ David M. Krinsky
`Jan M. Carroll
`BARNES & THORNBURG LLP
`11 South Meridian Street
`Indianapolis, IN 46204
`(317) 236-1313
`Fax: (317) 231-7433
`jan.carroll@btlaw.com
`
`Bruce R. Genderson
`Adam L. Perlman
`Ellen E. Oberwetter
`Dov P. Grossman
`David M. Krinsky
`Megan A. Hughes
`Andrew V. Trask
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street N.W.
`Washington, DC 20005
`(202) 434-5000
`Fax: (202) 434-5029
`bgenderson@wc.com
`aperlman@wc.com
`eoberwetter@wc.com
`dgrossman@wc.com
`dkrinsky@wc.com
`mhughes@wc.com
`atrask@wc.com
`
`Attorneys for Plaintiff
`Eli Lilly and Company
`
`
`
`
`
`
`
`Case 1:10-cv-01376-TWP-DKL Document 319 Filed 09/04/13 Page 3 of 3 PageID #: 6308
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on September 3, 2013, I caused a copy of the foregoing
`
`Stipulation Regarding Post-Trial Briefing Schedule to be served electronically via operation
`
`of the Court’s CM/ECF system upon the following:
`
`David O. Tittle
`Kandi K. Hidde
`BINGHAM GREENEBAUM DOLL LLP
`dtittle@bgdlegal.com
`khidde@ bgdlegal.com
`
`Daryl L. Wiesen
`Elaine Herrmann Blais
`Emily L. Rapalino
`Michael B. Cottler
`Brian J. Prew
`Natasha E. Daughtrey
`GOODWIN PROCTER LLP
`dwiesen@goodwinprocter.com
`erapalino@goodwinprocter.com
`mcottler@goodwinprocter.com
`bprew@goodwinprocter.com
`ndaughtrey@goodwinprocter.com
`
`Attorneys for Defendants Teva Parenteral
`Medicines, Inc., APP Pharmaceuticals, LLC,
`Pliva Hrvatska d.o.o., Teva Pharmaceuticals
`USA, Inc., and Barr Laboratories, Inc.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` /s/ David M. Krinsky
`David M. Krinsky
`
`3